Bora Pharmaceuticals

Bora Pharmaceuticals is an international pharmaceutical services company founded in 2007, dedicated to improving global health. As a contract development and manufacturing organization (CDMO), it specializes in complex pharmaceutical products, including oral solid dosage forms, biologics, liquids, powders, semi-solids, and sterile injectables. Bora supports the entire pharmaceutical development process, from clinical stages to commercial manufacturing and packaging.

The company operates cGMP-compliant manufacturing facilities in North America and Asia, adhering to the highest international standards. Bora's business model focuses on scalable, high-quality CDMO growth and innovative drug development, particularly in specialty pharmaceuticals and rare diseases. Its product portfolio includes a variety of therapeutic categories, and it is committed to advancing new drug technologies.

Bora Pharmaceuticals emphasizes operational excellence and quality, guided by its core values of Promises, Partnerships, Pride, People, and Progress. The company aims for sustainable growth and is focused on corporate governance and environmental, social, and governance (ESG) initiatives, including net-zero targets.